Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.
Cells. 2022 Jun 28;11(13):2045. doi: 10.3390/cells11132045.
Mitochondrial protein acetylation is associated with a host of diseases including cancer, Alzheimer's, and metabolic syndrome. Deciphering the mechanisms regarding how protein acetylation contributes to disease pathologies remains difficult due to the complex diversity of pathways targeted by lysine acetylation. Specifically, protein acetylation is thought to direct feedback from metabolism, whereby nutritional status influences mitochondrial pathways including beta-oxidation, the citric acid cycle, and the electron transport chain. Acetylation provides a crucial connection between hepatic metabolism and mitochondrial function. Dysregulation of protein acetylation throughout the cell can alter mitochondrial function and is associated with numerous liver diseases, including non-alcoholic and alcoholic fatty liver disease, steatohepatitis, and hepatocellular carcinoma. This review introduces biochemical mechanisms of protein acetylation in the regulation of mitochondrial function and hepatic diseases and offers a viewpoint on the potential for targeted therapies.
线粒体蛋白乙酰化与许多疾病有关,包括癌症、阿尔茨海默病和代谢综合征。由于赖氨酸乙酰化靶向的途径具有复杂的多样性,因此解析蛋白乙酰化如何导致疾病病理的机制仍然很困难。具体而言,人们认为蛋白乙酰化可以从代谢中提供反馈,其中营养状况会影响包括β-氧化、柠檬酸循环和电子传递链在内的线粒体途径。乙酰化提供了肝代谢和线粒体功能之间的关键联系。整个细胞中蛋白乙酰化的失调会改变线粒体功能,并与许多肝病有关,包括非酒精性和酒精性脂肪肝疾病、脂肪性肝炎和肝细胞癌。本文介绍了蛋白乙酰化在调节线粒体功能和肝脏疾病中的生化机制,并就靶向治疗的潜力提出了观点。